Home › Funds › Citigroup Inc › EBS
Citigroup Inc position in EBS
EMERGENT BIOSOLUTIONS INC · Health Care
Latest position (Q2 2026)65.92K sh
Reported value held$552.41K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 40.56K | $2.03M | New |
| Q4 2021 | 136.33K | $5.93M | Add |
| Q1 2022 | 65.14K | $2.67M | Reduce |
| Q2 2022 | 149.62K | $4.64M | Add |
| Q3 2022 | 234.32K | $4.92M | Add |
| Q4 2022 | 208.96K | $2.47M | Reduce |
| Q1 2023 | 327.36K | $3.39M | Add |
| Q2 2023 | 193.99K | $1.43M | Reduce |
| Q3 2023 | 15.07K | $51.23K | Reduce |
| Q4 2023 | 7.58K | $18.20K | Reduce |
| Q1 2024 | 12.37K | $31.29K | Add |
| Q2 2024 | 21.93K | $149.57K | Add |
| Q3 2024 | 39.64K | $330.98K | Add |
| Q4 2024 | 85.52K | $817.56K | Add |
| Q1 2025 | 87.18K | $423.71K | Add |
| Q2 2025 | 34.19K | $218.12K | Reduce |
| Q3 2025 | 3.91K | $34.50K | Reduce |
| Q4 2025 | 11.24K | $138.94K | Add |
| Q1 2026 | 13.05K | $108.31K | Add |
| Q2 2026 | 65.92K | $552.41K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EBS
- Vanguard Group 3.55M sh · $43.93M · Q4 2025
- BlackRock Inc 4.72M sh · $39.53M · Q2 2026
- Geode Capital Management 1.34M sh · $11.21M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $10.06M · Q2 2026
- Millennium Management 1.07M sh · $8.98M · Q2 2026
- AQR Capital Management 1.04M sh · $8.72M · Q2 2026
- Goldman Sachs Group 1.04M sh · $8.68M · Q2 2026
- D. E. Shaw & Co 900.11K sh · $7.54M · Q2 2026
- Prudential Financial 805.89K sh · $6.75M · Q2 2026
- Renaissance Technologies 683.25K sh · $5.73M · Q2 2026
- Northern Trust Corp 621.47K sh · $5.21M · Q2 2026
- Two Sigma Investments 488.28K sh · $4.09M · Q2 2026